SEMD is a systemic disorder affecting multiple organ systems, including the skeletal, ocular, and possibly neurological systems; therefore, subsequent research should investigate the role of RSPRY1 in a broader range of cell types and tissues in order to more fully elucidate its systemic impact. The gene discussed is RSPRY1; the disease is spondyloepimetaphyseal dysplasia.